Related Experiment Videos
[Slowly progressive IDDM].
1Toranomon Hospital, Department of Endocrinology and Metabolism.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 13, 1999
Summary
This study reveals a distinct subtype of slowly progressive autoimmune diabetes in Japanese adults, characterized by gradual beta-cell loss and specific genetic markers. Early insulin therapy may help preserve remaining beta-cell function.
Area of Science:
- Endocrinology
- Immunology
- Genetics
Context:
- Non-insulin-dependent diabetes mellitus (NIDDM) with islet cell antibodies (ICA) represents a distinct clinical entity.
- Understanding the natural history of beta-cell function in this population is crucial for effective management.
Purpose:
- To investigate the long-term natural history of beta-cell function in ICA-positive NIDDM.
- To characterize the distinct features of this diabetes subtype compared to acute onset IDDM.
- To evaluate the efficacy of low-dose insulin therapy.
Summary:
- A 10-year prospective study identified a slowly progressive form of autoimmune diabetes (IDDM) in Japanese adults.
- Key features include late onset, non-insulin requirement at diagnosis, slow beta-cell failure, specific antibody profiles (ICA, GAD), incomplete beta-cell loss, pancreatic atrophy, CD8+ T cell infiltration, and genetic associations (HLA, mitochondrial DNA).
- This subtype contrasts sharply with acute onset IDDM, suggesting a unique pathological process.
Impact:
- Identifies a distinct subtype of autoimmune diabetes in the Japanese population.
- Provides insights into the slow autoimmune destruction of beta-cells.
- Suggests that low-dose insulin therapy can mitigate immunological beta-cell failure, potentially altering disease progression.